Browse by all authors Browse By Author ID - Cooksley, W. Graham

Browse Results (62 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Sing, G. K., Ladhams, A., Arnold, S., Parmar, H., Chen, X., Cooper, J., Butterworth, L., Stuart, K., D'Arcy, D. and Cooksley, W. G. E. (2001) A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients. Journal of Viral Hepatitis, 8 1: 19-29. doi:10.1046/j.1365-2893.2001.00260.x 38   22 Cited 23 times in Scopus23 0
Sing, G., Li, D., Chen, X., Macnaughton, T. B., Lichanska, A., Butterworth, L. A., Ladhams, A. and Cooksley, W. G. E. (2001) A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: Evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology, 33 5: 1288-1298. doi:10.1053/jhep.2001.24026 67   18 Cited 20 times in Scopus20 0
Basuni, A. A., Butterworth, L. A., Cooksley, G., Locarnini, S. and Carman, W. F. (2000) An efficient extraction method from blood clots for studies requiring both host and viral DNA. Journal of Viral Hepatitis, 7 3: 241-243. 117   8
Sugauchi, F., Mizokami, M., Orito, E., Ohno, T., Kato, H., Suzuki, S., Kimura, Y., Ueda, R., Butterworth, L. A. and Cooksley, W. G. E. (2001) A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. Journal of General Virology, 82 4: 883-892. 54   140
Carreno, V. and Cooksley, W. G. E. (1999). A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. In: 50th Annual Meeting, American Association for the Study of Liver Diseases. 50th Annual Meeting of the American Association for the Study of Liver Diseases, Wyndham Anatole Hotel, Dallas, (). 5-9 November, 1999. 43  
Liaw, Yun-Fan, Kao, Jia-Horng, Piratvisuth, Teerha, Chan, Henry Lik Yuen, Chien, Rong-Nan, Liu, Chun-Jen, Gane, Ed, Locarnini, Stephen, Lim, Seng-Gee, Han, Kwang-Hyub, Amarapurkar, Deepak, Cooksley, Graham, Jafri, Wasim, Mohamed, Rosmawati, Hou, Jin-Lin, Chuang, Wan-Long, Lesmana, Laurentius A., Sollano, Jose D., Suh, Dong-Jin and Omata, Masao (2012) Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update. Hepatology International, 6 3: 531-561. doi:10.1007/s12072-012-9365-4 571 4 187 Cited 206 times in Scopus206 1
Swain, Mark G., Lai, Ming-Yang, Shiffman, Mitchell L., Cooksley, W. Graham E., Zeuzem, Stefan, Dieterich, Douglas T., Abergel, Armand, Pessoa, Mario G., Lin, Amy, Tietz, Andreas, Connell, Edward V. and Diago, Moises (2010) A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. Gasteroenterology, 139 5: 1593-1601. doi:10.1053/j.gastro.2010.07.009 62   107 Cited 116 times in Scopus116 10
Perrillo, Robert P., Gish, Robert G., Peters, Marion, Keeffe, Emmet B., Alberti, Alfredo, Buti, Maria, Cooksley, W. Graham E., Fried, Michael W., Hadziyannis, Stephanos J., Liaw, Yun–Fan, Naoumov, Nikolai V., Schiff, Eugene R., Thio, Chloe L., Tsai, Naoky and Schalm, Solko (2006) Chronic hepatitis B: A critical appraisal of current approaches to therapy. Clinical Gastroenterology And Hepatology, 4 2: 233-248. doi:10.1016/S1542-3565(05)00983-3 70   23 Cited 25 times in Scopus25 0
Cooksley, W. G. E. (2000) Consensus statement on the role of hepatitis A vaccination in patients with chronic liver disease. Journal of Viral Hepatitis, 7 Suppl 1: 29-30. 34  
Sullivan, S. D., Jensen, M., Bernstein, D. E., Hassanein, T. I., Foster, G. R., Lee, S. S., Cheinquer, H., Craxi, A., Cooksley, G., Klaskala, W., Pettit, K., Patel, K. K. and Green, J. (2004) Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. American Journal of Gastroenterology, 99 8: 1490-1496. doi:10.1111/j.1572-0241.2004.30286.x 68   39 Cited 47 times in Scopus47 0
Cooksley, G. (2005) Does the Addition of Lamivudine to Peginterferon a-2a sustain Response Rates in Patients with HBeAG Negative Hepatitis B?. Nature Clinical Practice. Gastroenterology & Hepatology, 2 1: 12-13. doi:10.1038/ncpgasthep0068 35   1 Cited 0 times in Scopus0 0
Cooksley, W. G. E. (2010) Do we need to determine viral genotype in treating chronic hepatitis B?. Journal of Viral Hepatitis, 17 9: 601-610. doi:10.1111/j.1365-2893.2010.01326.x 39   21 Cited 27 times in Scopus27 0
Butterworth, L. A., Cooksley, W. G. E., Crawford, D., D'Arcy, D., Dorrington, L., Garrett, L., Hourigan, K., Macdonald, G. and Walker, D. (2000). Early detection of response to interferon treatment in chronic HCV. In: 10th International Symposium on Viral Hepatitis and Liver Disease. 10th Int Symp on Viral Hepatitis and Liver Disease, Atlanta, USA, (). 9-13 April, 2000. 53  
Butterworth, L. A., Cooksley, W. G. E., Crawford, D., D'Arcy, D., Dorrington, L., Hourigan, K. and Walker, D. (1999). Early detection of sustained responders to Interferon treatment. In: Third International Conference on Therapies for Viral Hepatitis. 3rd International Conference on Therapies for Viral Hepatitis, Ritz Carlton, Maui, Hawaii, (). 12-16 December, 1999. 41  
Cooksley, W. G. E. (2000). Effect of chronic hepatitis C on health-related quality of life. In: Digestive Diseases Week, American Association for the Study of Liver Disease. Digestive Diseases Week, San Diego, USA, (). 21-24 May, 2000. 40  
Cooksley, W. G. E., Crawford, D., Gowans, E. J., Harrison, M., Lott, W. B., Macdonald, G. and Sloots, T. (2000). Effects of cobalamin on hepatitis C virus translation and replication. In: Annual Mtg of the American Association for the Study of Liver Disease. Ann Mtg of American Assn for the Study of Liver Disease, Dallas, Texas, ((abstract)). 27-31 Oct, 2000. 48  
Cooksley, G., AI463026 Benefits of Entecavir for Hepatitis B Liver Disease (BEHoLD) Study Group and et al. (2008) Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks. Hepatology, 48 1: 99-108. doi:10.1002/hep.22323 58   105 Cited 114 times in Scopus114 0
Bates, P. R., McCombe, P. A., Sheean, G. L., Cooksley, W. G. E. and Pender, M. P. (1993) Failure to Detect Measles Virus Sequences in Lymphocytes of Patients with Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 23 1: 55-55. doi:10.1111/j.1445-5994.1993.tb00539.x 497 125 0 0
Fried, Michael W., Piratvisuth, Teerha, Lau, George K. K., Marcellin, Patrick, Chow, Wan-Cheng, Cooksley, Graham, Luo, Kang-Xian, Paik, Seung Woon, Liaw, Yun-Fan, Button, Peter and Popescu, Matei (2008) HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology, 47 2: 428-434. doi:10.1002/hep.22065 115   121 Cited 138 times in Scopus138 0
Jazayeri, M., Basuni, A. A., Sran, N., Gish, R., Cooksley, G., Locarnini, S. and Carman, W. F. (2004) HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. Journal of Viral Hepatitis, 11 6: 488-501. doi:10.1111/j.1365-2893.2004.00534.x 48   18 Cited 30 times in Scopus30 0
Van Damme, Pierre, Banatvala, J., Fay, O., Iwarson, S., McMahon, B., Van Herck, K., Shouval, D., Bonanni, P., Connor, B., Cooksley, G., Leroux-Roels, G., Von Sonnenburg, F. and International Consensus Group on Hepatitis A Virus Immunity (2003) Hepatitis A booster vaccination: is there a need?. Lancet, 362 9389: 1065-1071. doi:10.1016/S0140-6736(03)14418-2 156   112 Cited 156 times in Scopus156 0
Graham Cooksley, W. (2011) Hepatitis B genotypes: Role of testing in clinical practice. Current Hepatitis Reports, 10 2: 79-86. doi:10.1007/s11901-011-0097-z 21   Cited 0 times in Scopus0 0
John, T. J. and Cooksley, William G.E. (2005) Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?. Journal of Gastroenterology and Hepatology, 20 1: 5-10. doi:10.1111/j.1400-1746.2004.03398.x 238   29 Cited 33 times in Scopus33 0
Jazayeri, Mohammed S., Basuni, Ashraf A., Cooksley, Graham, Locarnini, Stephen and Carman, William F. (2004) Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region. Journal of Hepatology, 41 1: 139-146. doi:10.1016/j.jhep.2004.03.025 50   22 Cited 28 times in Scopus28 0
Powell, Elizabeth E., Pender, Michael P., Chalk, Jonathan B., Parkin, Philip J., Strong, Russell, Lynch, Stephen, Kerlin, Paul, Cooksley, W. Graham, Cheng, Wendy and Powell, Lawrie W. (1990) Improvement in Chronic Hepatocerebral Degeneration Following Liver Transplantation. Gastroenterology, 98 4: 1079-1082. 377 800 38
Roberts, R., Cooksley, G., Shaw, D., Berns, H. K., Brandl, M. T., Fettner, S. H., Hill, G., Ipe, D., Klumpp, K., Mannino, M., O'Mara, E., Tuo, Y. and Washington, C. B. (2006). Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic hcv patients. In: Journal of Hepatology. Abstracts of The 1st Annual Meeting of the European Association for the Liver. 41st Annual Meeting of the European Association for the Study of the Liver, Vienna, Austria, (S269-S269). 26-30 April 2006. doi:10.1016/S0168-8278(06)80731-2 147   17 0
Alvarez, F., Berg, P., Bianchi, F., Burroughs, A., Cancado, E., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V., Donaldson, P. T., Eddleston, A. L., Fainboim, L., Heathcote, J., Homberg, J., Hoofnagle, J. H., Kakumu, S., Krawitt, E. L., Mackay, I. R., MacSween, R. N., Maddrey, W. C., Manns, M. P., McFarlane, I. G., Meyer zum Buschenfelde, K., Miele-Vergani, G., Nakanuma, Y., Nishioka, M., Penner, E., Porta, G., Portmann, B. C. and Reed, W. D. (1999) International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. Journal of Hepatology, 31 5: 929-938. 474   326
Powell, L. W., Bassett, M. and Cooksley, W. G. E. (2006). Liver Function Tests in Abnormal Laboratory Results. In Geoffrey Kellerman (Ed.), Abnormal Laboratory Results 2nd ed. (pp. 88-94) North Ryde, N.S.W.: McGraw-Hill. 193  
Conrad, S., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006) Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Chronic Illness, 2 2: 121-131. doi:10.1177/17423953060020020701 82   Cited 29 times in Scopus29 0
Pawlotsky, J. M., De Gendt, S., Beaucourt, S., Lopez Goncales, F., Butterworth, L. A. and Cooksley, W. G. E. (1999). Molecular epidemiology of hepatitis C virus genotype 3a in intravenous drug users (IVDUs). In: HCV Meeting. HCV Meeting, Bethesda, Maryland, (). April, 1999. 71  
Morice, Yoann, Cantaloube, Jean-Francois, Beaucourt, Stephanie, Barbotte, Laetitia, De Gendt, Sija, Lopes Goncales, Fernando, Butterworth, Lesley, Cooksley, Graham, Gish, Robert G., Beaugrand, Michel, Fay, Fabian, Fay, Oscar, Gonzalez, Jorge E., Martins, Regina Maria Bringel, Dhumeaux, Daniel, Vanderborght, Bart, Stuyver, Lieven, Sablon, Erwin, de Lamballerie, Xavier and Pawlotsky, Jean-Michel (2006) Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. Journal of Medical Virology, 78 10: 1296-1303. doi:10.1002/jmv.20692 108   31 Cited 32 times in Scopus32 0
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G., Lee, S. S., Balart, R., Reindollar, R., Reddy, R., Wright, T. and DePamphilis, J. (1999). Multinational evaluation of the efficacy and safety of once-weekly peginterferon a-2a (PEG-IFN) in patients with chronic hepatitis C (CHC) with compensated cirrhosis. In: 50th Annual Meeting, American Association for the Study of Liver Diseases. 50th Annual Meeting of the American Association for the Study of Liver Diseases, Wyndham Anatole Hotel, Dallas, (). 5-9 November, 1999. 71  
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G., Lee, S. S., Balart, L., Reindollar, R., Reddy, R., Wright, T., Lin, A., Hoffman, J. and De Pamphilis, J. (2000) Multinational evaluation of the efficacy and safety of one-weekly Peginterferon a-2a (PEG (40K)-IFNa-2a) in patients with chronic hepatitis C (CHC) with compensated cirrhosis. New England Journal of Medicine, 343 23: 1673-1680. 53  
Cooksley, William Graham Earnshaw (2010) Natural history of chronic hepatitis B: Extending the REVEAL study. Liver International, 30 8: 1085-1086. doi:10.1111/j.1478-3231.2010.02277.x 31   2 Cited 2 times in Scopus2 0
Cooksley, W. G. E. (1999) Natural history of Hepatitis C. Italian Journal of Gastroenterology and Hepatology, 31 1: 1-3. 31   2
Cooksley, G. (2005) Optimising treatment of hepatitis C. Romanian Journal of Gastroenterology, 14 Supplement 17: . 43  
Lau, George, K. K., Piratvisuth, Teerha, Luo, Kang Xian, Marcellin, Patrick, Thongsawat, Satawat, Cooksley, Graham, Gane, Edward, Fried, Michael, W., Chow, Wan Cheng, Paik, Seung Woon, Chang, Wen Yu, Berg, Thomas, Flisiak, Robert, McCloud, Philip and Pluck, Nigel (2005) Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B. New England Journal of Medicine, 352 26: 2682-2695. doi:10.1056/NEJMoa043470 108   713 Cited 903 times in Scopus903 0
Cooksley, W. G. E., Lai, M-Y., Piratvisuth, T., Wang, Y-J., Mahachai, V., Chao, Y-C., Tanwandee, T., Chutaputti, A., Chang, W-Y, Zahm, F. E. and Pluck N. (2004). Peginterferon alfa-2A (PEGASYSA R): Efficacy in patients with difficult-to-treat HBV.. In: Jilbert, A. R., Grgacic, E., Vickery, K. J., Burrell, C. J. and Cossart, Y. E., Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease (2003). 11th International Symposium on Viral Hepatitis and Liver Disease (2003), Sydney, Australia, (526-527). 6-10 April, 2003. 67  
Cooksley, William G.E., Piratvisuth, T., Lee, S.-D., Mahachai, V., Chao, Y.-C., Tanwandee, T., Chutaputti, A., Yu Chang, W., Zahm, F. E. and Pluck, N. (2003) Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. Journal of Viral Hepatitis, 10 4: 298-305. doi:10.1046/j.1365-2893.2003.00450.x 77   252 Cited 379 times in Scopus379 0
Cooksley, W. Graham E. (2005) Peginterferon-alpha 2a for the Treatment of Hepatitis B Infection. Expert Opinion on Pharmacotherapy, 6 8: 1373-1380. doi:10.1517/14656566.6.8.1373 66   5 Cited 8 times in Scopus8 0
Craxi, A. and Cooksley, W. G. (2003) Pegylated Interferons for Chronic Hepatitis B. Antiviral research, 60 2: 87-89. doi:10.1016/j.antiviral.2003.08.015 28   29 Cited 41 times in Scopus41 0
Cooksley, William G.E. (2005) Pegylated Interferons in Chronic HBV: Alone or As Combination Therapy. Current Hepatitis Reports, 4 34-38. 51  
Basuni, A. A., Butterworth, L., Cooksley, G., Locarnini, S. and Carman, W. F. (2004) Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine, 22 21-22: 2791-2799. doi:10.1016/j.vaccine.2004.01.046 97   26 Cited 27 times in Scopus27 0
Conrad, S., Macdonald, G., Garrett, L., Cooksley, W. G. E. and Dunne, M. P. (2000). Quality of life in chronic hepatitis C infection. In: Hepatology: Abstracts of the American Association for the Study of Liver Disease. American Association for the Study of Liver Disease, Dallas, Texas, (567A-567A). 27-31 Ocobert, 2000. 47  
Berg, C., Goncales, F. L., Bernstein, D. E., Sette, H., Rasenack, J., Diago, M., Jensen, D. M., Graham, P. and Cooksley, William G.E. (2006) Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin. Journal Of Viral Hepatitis, 13 7: 435-440. doi:10.1111/j.1365-2893.2006.00727.x 85   33 Cited 42 times in Scopus42 1
Roberts, Stuart K., Cooksley, Graham, Dore, Gregory J., Robson, Richard, Shaw, David, Berns, Heather, Hill, George, Klumpp, Klaus, Najera, Isabel and Washington, Carla (2008) Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic Hepatitis C. Hepatology, 48 2: 398-406. doi:10.1002/hep.22321 54   69 Cited 70 times in Scopus70 0
Schramm, T. M., Lawford, B., Macdonald, G. A. and Cooksley, W. G. E. (2000) Sertraline treatment of interferon-alfa-induced depressive disorder. Medical Journal of Australia, 173 7: 359-361. 128   79
Lang, C. A., Conrad, S., Garrett, L., Battistutta, D., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006) Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. Journal of Pain And Symptom Management, 31 4: 335-344. doi:10.1016/j.jpainsymman.2005.08.016 79   33 Cited 38 times in Scopus38 3
Hui, A. Y., Chan, H. L.-Y., Cheung, A. Y.-K., Cooksley, G. and Sung, J. J.-Y. (2005) Systematic review: Treatment of chronic hepatitis B virus infection by pegylated interferon. Alimentary Pharmacology and Therapeutics, 22 6: 519-528. doi:10.1111/j.1365-2036.2005.02616.x 56   32 Cited 39 times in Scopus39 0
Hassanein, T., Cooksley, G., Sulkowski, M., Smith, C., Marinos, G., Lai, M-Y., Pastore, G., Trejo-Estrada, R., Horta e Vale, A., Wintfeld, N. and Green, J. (2004) The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. Journal of Hepatology, 40 4: 675-681. doi:10.1016/j.jhep.2003.12.014 64   70 Cited 73 times in Scopus73 0

Page 1 of 2

Result Pages:    1 2  next › last »